Trading Tech

Reaching for the buy side

InfoReach, the Chicago-based provider of execution management and FIX systems that has garnered significant buy-side support in the US since its founding in 1995, is the subject of this month’s product overview.

Spotlight on Paul Migliore

Paul Migliore, recently appointed chief executive of Citisoft’s North American practice, speaks with Stewart Eisenhart about his new role at Citisoft, and how its clients’ approaches to strategy and technology have evolved

The changing face of OMSs

The global investment management industry is experiencing an increasingly rapid rate of change, creating a challenge for portfolio managers, traders and providers of trading systems alike. LatentZero's Richard Hooke explains how buy-side order management…

A case in point

Over the past several months, copious amounts of editorial ink have been devoted in this and other buy-side publications to the increasing interest of investment and hedge fund managers in execution management systems (EMS). Interest has, in turn, given…

Bloomberg Readies "On-Demand" Feed

Bloomberg is readying a new datafeed, which will provide the same data as its B-Pipe feed, but in an "interactive" delivery model that allows subscribers to choose the instruments on which they want to receive data, industry sources tell Inside Market…

Exegy Conceives Appliance "Family"

St. Louis-based ticker plant technology vendor Exegy is planning to introduce a range of applications based on its high-performance hardware appliance, to expand the capabilities of its technology to provide competitive advantage in other areas of the…

Interactive Data Cranks Opra Conflation Tool

Interactive Data Corp. will this week roll out new tick mitigation techniques on its Essential Options conflated feed of data from the Options Price Reporting Authority, in a bid to reduce bandwidth required for the data and ease the pressure of dealing…

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here